Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 5Unknown 2Terminated 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 2Cholangiocarcinoma 2Neoplasms 1Biliary Tract Neoplasms 1

Interventions

Gemcitabine 78Fluorouracil 27Oxaliplatin 24130-nm albumin-bound paclitaxel 24Leucovorin 18Capecitabine 15Albumin-Bound Paclitaxel 15S 1 (combination) 14Taxes 12Irinotecan 11pembrolizumab 9folfirinox 9Radiosurgery 9Radiotherapy 7Drug Therapy 7Cisplatin 7irinotecan sucrosofate 6Pancreaticoduodenectomy 5Paclitaxel 5Injections 5Docetaxel 5Blood Specimen Collection 5apatinib 4Radiofrequency Ablation 4Radiation 4Biopsy 4tislelizumab 3rubitecan 3nimotuzumab 3camrelizumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Pancreatic Neoplasms × Cholangiopancreatography, Endoscopic Retrograde × Clear all
NCT03069664 2022-08-16

Palliative Pancreatic Duct Stenting in Patients With Inoperable Pancreatic Cancer

Helsinki University Central Hospital

Phase NA Unknown
40 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT03063554 2017-02-24

BILPAL

Weill Medical College of Cornell University

Phase NA Unknown
120 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡